Weekly Low-Dose Docetaxel for Salvage Chemotherapy in Pretreated Elderly or Poor Performance Status Patients with Non-small Cell Lung Cancer

Although docetaxel monotherapy has shown clinical benefits for previously treated patients with advanced non-small cell lung cancer (NSCLC), the efficacy of salvage docetaxel chemotherapy for elderly patients or patients with poor performance status (PS) is controversial. Therefore, we conducted a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Keun-Wook, Lim, Joo Han, Kim, Jee Hyun, Lee, Choon-Taek, Lee, Jong Seok
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610665/
https://www.ncbi.nlm.nih.gov/pubmed/19119442
http://dx.doi.org/10.3346/jkms.2008.23.6.992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610665/
https://www.ncbi.nlm.nih.gov/pubmed/19119442
http://dx.doi.org/10.3346/jkms.2008.23.6.992

Ejemplares similares